Clorox Co
CLX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$973.00 | Ptvr | Dqntxnrnr |
Despite Navigating Murky Waters in the Near Term, We Think Clorox's Competitive Prowess Should Hold
Business Strategy and Outlook
The pandemic prompted consumers to scour the shelves for Clorox's fare, boosting sales. And even as volume growth is decelerating, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as sales remain well above where they were before the pandemic (to the tune of 5% in its fiscal fourth quarter). This prowess is further evidenced by its disinfecting wipes offering, which posted its fourth-consecutive quarter of market share gains.